Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2012; 18(3): 244-250
Published online Jan 21, 2012. doi: 10.3748/wjg.v18.i3.244
Published online Jan 21, 2012. doi: 10.3748/wjg.v18.i3.244
Figure 5 Effects of urokinase plasminogen activator knockdown on KKU-M213 cell invasion.
A: Level of urokinase plasminogen activator (uPA) mRNA of the cells transfected with siRNA against uPA or non-targeting siRNA for 48 and 72 h were determined by real-time reverse transcriptase polymerase chain reaction. Significant difference is indicated by aP < 0.05; B: Cells transfected with siRNA for 66 h were analyzed for cell invasiveness using Transwell in vitro invasion assay. The results were presented as mean ± SE from three independent experiments.
- Citation: Thummarati P, Wijitburaphat S, Prasopthum A, Menakongka A, Sripa B, Tohtong R, Suthiphongchai T. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis. World J Gastroenterol 2012; 18(3): 244-250
- URL: https://www.wjgnet.com/1007-9327/full/v18/i3/244.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i3.244